Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|February 10, 2017
Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide HydrolaseAlessio De Simone, Debora Russo, Gian Filippo Ruda, et al.Carbohydrate Polymers|April 26, 2018
Antimicrobial, antioxidant, and waterproof RTV silicone-ethyl cellulose composites containing clove essential oilJosé A Heredia-Guerrero, Luca Ceseracciu, Susana Guzman-Puyol, et al.European Journal of Medicinal Chemistry|December 27, 2021
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disordersStefania Demuro, Conall Sauvey, Shailesh K Tripathi, et al.Oncotarget|December 29, 2016
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cellsIlaria Penna, Arianna Gigoni, Delfina Costa, et al.Journal of Medicinal Chemistry|August 8, 2025
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based InhibitorsGiambattista Marotta, Francesca Massenzio, Jose Ortega, et al.Journal of Medicinal Chemistry|December 8, 2020
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase InhibitorsSamantha Caputo, Simona Di Martino, Vincenzo Cilibrasi, et al.Journal of Medicinal Chemistry|April 29, 2026
A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) InhibitorsStefania Demuro, Debora Russo, Ilaria Penna, et al.Journal of Medicinal Chemistry|March 17, 2020
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase InhibitorsSimona Di Martino, Piero Tardia, Vincenzo Cilibrasi, et al.Angewandte Chemie (International Ed. in English)|July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple SclerosisMarco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.Journal of Medicinal Chemistry|September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR PotentiatorsNicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.Pageof 5